In the case of Microsoft Corp. v. AT&T, the Supreme Court delivered patents another blow, according to guest columnist Shane Brunner, an attorney with Michael Best & Friedrich. By limiting the reach of patents, the nation's high court made it clear that United States patent...
The Wisconsin Department of Workforce Development is making up to $850,000 in state grants available to businesses, trade associations, and colleges for the training of high-tech workers. Grants will be offered to train workers in biotechnology, advanced manufacturing, stem cell research, and renewable energy. ...
Gov. Jim Doyle has established a goal of capturing 10 percent of the stem cell market by 2015, and he has announced a $1 million funding commitment to help bring that about. The state will invest $1 million in Stemina Biomarker Discovery, a start-up company...
ProCertus BioPharm, an oncology-based pharmaceutical company, has closed on a $2.3 million stock financing led by Venture Investors. ProCertus develops therapeutics to protect cancer patients against the side effects of chemotherapy and radiotherapy, and will use the financing to begin clinical trials on cancer patients. ...
The Supreme Court decision in KSR International vs. Teleflex not only clarified the “obviousness” standard for patents, it sent a message about adhering to Supreme Court precedents, writes John Scheller, an attorney with Michael Best & Friedrich. In this guest column for WTN, Scheller says...
The Wisconsin delegation hit the ground running at BIO 2007, an international conference for the biotechnology industry. Among the significant news generated at BIO was the announcement by Mark Underwood, president of Quincy Biosciences, that the company has developed a preclinical compound for the...
Mason Wells is spinning off its venture capital business, but the move hardly spells doom for Wisconsin's attempts to generate more venture capital. Mason Wells Venture Funds will be spun into Broadwell Ventures, which will be managed by Dan Broderick and focus on biotechnology, pharmaceutical,...
Like the Olympic games, BIO 2007 in Boston truly is an international event, as about 25 percent of the attendees are from overseas, notes columnist Michael Rosen. In this edition of Yer Biotech Blues, Rosen points to participation from Australia, Malaysia, Singapore, China, Japan, Korea,...
How does Wisconsin stack up to the nation's best biotechnology hubs? This week in Boston, the state will have plenty to thump its chest about at the annual Biotechnology Industry Organization (BIO) Convention, writes columnist Tom Still. In this edition of Inside Wisconsin, he...
Advanced Cell Technology has reached an expanded licensing agreement with the Wisconsin Alumni Research Foundation that gives the company the commercial right to use human embryonic stem cells to develop certain human therapies. Advanced Cell Technology is the California company that says it has devised...